126 related articles for article (PubMed ID: 10788470)
41. Structural characterization suggests models for monomeric and dimeric forms of full-length ezrin.
Phang JM; Harrop SJ; Duff AP; Sokolova AV; Crossett B; Walsh JC; Beckham SA; Nguyen CD; Davies RB; Glöckner C; Bromley EH; Wilk KE; Curmi PM
Biochem J; 2016 Sep; 473(18):2763-82. PubMed ID: 27364155
[TBL] [Abstract][Full Text] [Related]
42. A structural and dynamic model for the interaction of interleukin-8 and glycosaminoglycans: support from isothermal fluorescence titrations.
Krieger E; Geretti E; Brandner B; Goger B; Wells TN; Kungl AJ
Proteins; 2004 Mar; 54(4):768-75. PubMed ID: 14997572
[TBL] [Abstract][Full Text] [Related]
43. Design and initial characterization of a circular permuted variant of the potent HIV-inactivating protein cyanovirin-N.
Barrientos LG; Louis JM; Hung J; Smith TH; O'Keefe BR; Gardella RS; Mori T; Boyd MR; Gronenborn AM
Proteins; 2002 Feb; 46(2):153-60. PubMed ID: 11807943
[TBL] [Abstract][Full Text] [Related]
44. Disulfide bond assignments and secondary structure analysis of human and murine interleukin 10.
Windsor WT; Syto R; Tsarbopoulos A; Zhang R; Durkin J; Baldwin S; Paliwal S; Mui PW; Pramanik B; Trotta PP
Biochemistry; 1993 Aug; 32(34):8807-15. PubMed ID: 8364028
[TBL] [Abstract][Full Text] [Related]
45. Characterization of the recombinant extracellular domains of human interleukin-20 receptors and their complexes with interleukin-19 and interleukin-20.
Pletnev S; Magracheva E; Kozlov S; Tobin G; Kotenko SV; Wlodawer A; Zdanov A
Biochemistry; 2003 Nov; 42(43):12617-24. PubMed ID: 14580208
[TBL] [Abstract][Full Text] [Related]
46. A potent dimeric peptide antagonist of interleukin-5 that binds two interleukin-5 receptor alpha chains.
England BP; Balasubramanian P; Uings I; Bethell S; Chen MJ; Schatz PJ; Yin Q; Chen YF; Whitehorn EA; Tsavaler A; Martens CL; Barrett RW; McKinnon M
Proc Natl Acad Sci U S A; 2000 Jun; 97(12):6862-7. PubMed ID: 10823900
[TBL] [Abstract][Full Text] [Related]
47. Crystal structure of interleukin-19 defines a new subfamily of helical cytokines.
Chang C; Magracheva E; Kozlov S; Fong S; Tobin G; Kotenko S; Wlodawer A; Zdanov A
J Biol Chem; 2003 Jan; 278(5):3308-13. PubMed ID: 12403790
[TBL] [Abstract][Full Text] [Related]
48. Interaction of Alzheimer's A beta peptide with an engineered binding protein--thermodynamics and kinetics of coupled folding-binding.
Hoyer W; Härd T
J Mol Biol; 2008 Apr; 378(2):398-411. PubMed ID: 18358490
[TBL] [Abstract][Full Text] [Related]
49. Dimerization-induced folding of MST1 SARAH and the influence of the intrinsically unstructured inhibitory domain: low thermodynamic stability of monomer.
Constantinescu Aruxandei D; Makbul C; Koturenkiene A; Lüdemann MB; Herrmann C
Biochemistry; 2011 Dec; 50(51):10990-1000. PubMed ID: 22112013
[TBL] [Abstract][Full Text] [Related]
50. Characterization of monomeric and dimeric B domain of Staphylococcal protein A.
Karimi A; Matsumura M; Wright PE; Dyson HJ
J Pept Res; 1999 Oct; 54(4):344-52. PubMed ID: 10532240
[TBL] [Abstract][Full Text] [Related]
51. A helical coat protein recognition domain of the bacteriophage P22 scaffolding protein.
Tuma R; Parker MH; Weigele P; Sampson L; Sun Y; Krishna NR; Casjens S; Thomas GJ; Prevelige PE
J Mol Biol; 1998 Aug; 281(1):81-94. PubMed ID: 9680477
[TBL] [Abstract][Full Text] [Related]
52. Circular dichroism study on the conformational stability of the dimerization domain of transcription factor LFB1.
De Francesco R; Pastore A; Vecchio G; Cortese R
Biochemistry; 1991 Jan; 30(1):143-7. PubMed ID: 1988015
[TBL] [Abstract][Full Text] [Related]
53. Dimerization and folding of LC8, a highly conserved light chain of cytoplasmic dynein.
Barbar E; Kleinman B; Imhoff D; Li M; Hays TS; Hare M
Biochemistry; 2001 Feb; 40(6):1596-605. PubMed ID: 11327818
[TBL] [Abstract][Full Text] [Related]
54. Implication of the Transmembrane Domain in the Interleukin 10 Receptor Platform Oligomerisation.
Kuntzel T; Spenlé C; Pham-Van LD; Birmpili D; Riou A; Loeuillet A; Charmarke-Askar I; Bagnard D
Cells; 2023 May; 12(10):. PubMed ID: 37408195
[TBL] [Abstract][Full Text] [Related]
55. Conformational change coupling the dimerization and activation of KSHV protease.
Pray TR; Reiling KK; Demirjian BG; Craik CS
Biochemistry; 2002 Feb; 41(5):1474-82. PubMed ID: 11814340
[TBL] [Abstract][Full Text] [Related]
56. A heterodimerizing leucine zipper coiled coil system for examining the specificity of a position interactions: amino acids I, V, L, N, A, and K.
Acharya A; Ruvinov SB; Gal J; Moll JR; Vinson C
Biochemistry; 2002 Dec; 41(48):14122-31. PubMed ID: 12450375
[TBL] [Abstract][Full Text] [Related]
57. The Generation of an Engineered Interleukin-10 Protein With Improved Stability and Biological Function.
Minshawi F; Lanvermann S; McKenzie E; Jeffery R; Couper K; Papoutsopoulou S; Roers A; Muller W
Front Immunol; 2020; 11():1794. PubMed ID: 32849644
[TBL] [Abstract][Full Text] [Related]
58. The membrane form of the type II IL-1 receptor accounts for inhibitory function.
Neumann D; Kollewe C; Martin MU; Boraschi D
J Immunol; 2000 Sep; 165(6):3350-7. PubMed ID: 10975853
[TBL] [Abstract][Full Text] [Related]
59. The helical propensity of KLA amphipathic peptides enhances their binding to gel-state lipid membranes.
Arouri A; Dathe M; Blume A
Biophys Chem; 2013; 180-181():10-21. PubMed ID: 23792704
[TBL] [Abstract][Full Text] [Related]
60. A beta-sheet peptide inhibitor of E47 dimerization and DNA binding.
Ghosh I; Chmielewski J
Chem Biol; 1998 Aug; 5(8):439-45. PubMed ID: 9710566
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
